Study Title: A Phase II study of Atezolizumab and Bevacizumab in Child-Pugh B7 Hepatocellular Carcinoma (The AB7 Trial) Big Ten Cancer Research Consortium BTCRC-GI20-457
- Closed to Accrual at:
- Learn more:
- Publications and Presentations:
- 2022 ASCO GI Symposium
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Subscribe to the Big Ten CRC NewsletterXFacebookYouTube